Upload
donald-cunningham
View
218
Download
2
Embed Size (px)
Citation preview
Case Study: C. F.
• 52 year old woman presenting with new onset diabetes, presumably type 1.
• HPI: 6 week history of fatigue, thirst, blurred vision, polyuria
• PMH: hypothyroidism, hyperlipidemia, depression.
• Medications: simvastatin, duloxetine, metformin 850 mg bid, insulin glargine 8 units
• Family Hx: Father – Type 2 DM, Son Type 1 DM• SH: Married with 5 children (none > 9 lbs),
secretary
Case Study CF
• Physical exam– Wt. - 156.4 Ht. – 63” BP 132/82, HR 72,– Normal HEENT, Neck, Chest, Cardiovascular, Abdominal,
Neurologic
• Laboratories– HgA1C – 10.0%, glucose 268, normal renal and liver
function, normal urine microalbumin
What do you think of her diagnosis?
Type 1, Type 2 or LADA?
Objectives:
• Compare and contrast diagnostic and clinical criteria of type 1, type 2 diabetes and latent autoimmune diabetes (LADA) in the adult?
• Discuss role of autoimmunity in the pathogenesis of type 1 diabetes and LADA.
• Identify clinical characteristics & manifestations of autoimmunity vs. insulin resistance in differentiating diabetes typology.
Definition
• Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both.*
• The name 'diabetes mellitus' derives from:Greek: 'diabetes' – “siphon” or “to pass through”Latin: 'mellitus' – “honeyed” or “sweet”**
* Diagnosis and Classification of Diabetes Mellitus. ADA 2009.** http://science.jrank.org/pages/2044/Diabetes-Mellitus.html
Classification• Type 1 diabetes• Type 2 diabetes• Other
1. Genetic defects of beta cell function2. Genetic defects in insulin action3. Diseases of the exocrine pancreas4. Endocrinopathies5. Drug/ chemical - induced 6. Infections7. Uncommon forms of immune-mediated diabetes8. Genetic syndromes sometimes associated with diabetes
• Gestational diabetes mellitus
Epidemiology
• 20.8 million Americans (7% of US population)• About 10% have Type 1 DM• 14.6 million diagnosed• 6.2 million remain undiagnosed• 41 million have pre-diabetes• Lifetime risk for developing DM (Type 1 or 2) is 33 % in
males and 39% in females for individuals born in 2000• Up to 45% of newly diagnosed cases of DM in US
children and adolescents are type 2
AACE Diabetes Mellitus Guidelines, EndocrPract. 2007;13(Suppl 1) 2007
Type 1 diabetes mellitus• Absolute insulin deficiency
• Autoimmune destruction of the pancreaticβ cells – Islet-cell antibodies (ICA)– Glutamicacid decarboxylase [anti-GAD]– IA-2 and anti-insulin)
• Rapid onset
• Ketosis Prone
Diabetes Mellitus Type 1 & Autoimmune Diseases
• Hypothyroidism• Celiac disease• Addison’s Disease• Rheumatoid arthritis• Pernicious anemia• Vitiligo
Type 2 diabetes
• Central feature: Insulin resistance
• Relative impairment in insulin secretion (hyperinsulinemia may exist)
• Associated metabolic features (hyperlipidemia)
• Ketosis occurs rarely
Type 2 Diabetes: Insulin Resistance & β Cell Dysfunction
Pancreas
Insulin Resistance
Liver
Hyperglycemia
Islet Cell Degranulation;Reduced Insulin Content
Muscle Adipose Tissue
Decreased Glucose Transport & Activity
(expression) of GLUT4
Increased Lipolysis
↑GlucoseProduction
↓GlucoseUptake
ReducedPlasma Insulin
Increased Glucose Output
Cell Dysfunction
Elevated Plasma FFA
Type 2 Diabetes and Associated Factors
• Obesity• Sedentary lifestyle• Gradual onset• History
– Gestational diabetes– Family history– PCOS
• Hyperpigmented skin (acanthosisnigricans)
*A clinical screening tool identifies autoimmune diabetes in adults. Fourlanos S; Perry C; Stein MS; Stankovich J; Harrison LC; Colman PG. Diabetes Care. 2006 May;29(5):970-5
• Adult-onset diabetes with circulating islet antibodies but not requiring insulin therapy initially.
• Alternate references– Type 1.5 diabetes– Skinny Type 2 diabetes
• Typical characteristics– Age of onset > 50 years of age– Gradual onset with initial improvement to oral
agents/lifestyle changes.– BMI <25 kg/m2
– Personal or family history of autoimmune disease
Latent Autoimmune Diabetes in Adults (LADA)
Characteristics of Type 1, Type 2 and LADACharacteristic Type 1 Type 2 LADA
Age of Onset <35 >35 >35
Speed of Onset Rapid Slow Slow
Response to lifestyle modification or oral agents
Poor Good Initial mixed then worsening
Frequency of DKA High Low Low
Family History of DM Uncommon Common Uncommon
Personal/Family History Autoimmune Disease
Common Uncommon Common
Body Habitus Fit or lean Overweight to Obese
Normal to overweight
Acanthosisnigricans No Yes No
Metabolic syndrome No Yes No
C Peptide Level Undetectable Normal Low/Normal
Anti-GAD/Anti-ICA/Anti-IA2 Positive Negative Positive
Adapted from: Appel et al. (2009). J Am Acad Nurse Pract, 21(3), 156-159.
Followup Case Study – C. F.
• FollowupLaboratories– Glutamic Acid Carboxylase (GAD-65) – 94.9 (Reference 0-
1.5)– Islet cell antibody IgG 1:16 (Reference <1:4)– C Peptide – 0.9 (1.1-5.0)
Your thoughts on this woman’s diagnosis????
Type1 . . . Type 2 . . . LADA